Want to see NRIX full AI Analyst Report?
Nurix Therapeutics (NRIX) Ownership Overview
0.17% Insiders
17.91% Mutual Funds
0.75% Other Institutional Investors
16.74% ETFs
64.43% Public Companies and
Individual Investors
The ownership structure of Nurix Therapeutics (NRIX) stock is a mix of institutional, retail, and individual investors. Approximately 35.40% of the company’s stock is owned by Institutional Investors, 0.17% is owned by Insiders, and 64.43% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $26677593 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $57518594 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $5964881 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,234,187 | Institution | 5.04% | 121,014,403 | |
| 4,992,032 | Institution | 4.81% | 115,415,780 | |
| 4,658,556 | Institution | 4.49% | 107,705,815 | |
| 4,308,703 | Institution | 4.15% | 99,617,213 | |
| 3,710,877 | Institution | 3.58% | 85,795,476 | |
| 2,859,279 | Institution | 2.76% | 66,106,530 | |
| 1,779,531 | Institution | 1.71% | 41,142,757 | |
| 1,721,135 | Institution | 1.66% | 39,792,641 | |
| 1,517,575 | Institution | 1.46% | 35,086,334 | |
| 1,423,860 | Institution | 1.37% | 32,919,643 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,308,703 | Institution | 4.15% | 99,617,213 | |
| 1,517,575 | Institution | 1.46% | 35,086,334 | |
| 1,423,860 | Institution | 1.37% | 32,919,643 | |
| 1,323,464 | Institution | 1.28% | 30,598,488 | |
| 1,215,025 | Institution | 1.17% | 28,091,378 | |
| 1,145,329 | Institution | 1.10% | 26,480,006 | |
| 1,074,324 | Institution | 1.04% | 24,838,371 | |
| 945,380 | Institution | 0.91% | 21,857,186 | |
| 893,327 | Institution | 0.86% | 20,653,720 | |
| 598,762 | Institution | 0.58% | 13,843,377 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,275,161 | Institution | 3.16% | 79,455,406 | |
| 2,521,912 | Institution | 2.43% | 58,180,510 | |
| 2,484,187 | Institution | 2.39% | 57,310,194 | |
| 1,694,558 | Institution | 1.63% | 39,178,181 | |
| 1,114,166 | Institution | 1.07% | 27,029,667 | |
| 719,993 | Institution | 0.69% | 16,610,239 | |
| 679,964 | Institution | 0.66% | 15,686,769 | |
| 551,605 | Institution | 0.53% | 13,381,937 | |
| 460,441 | Institution | 0.44% | 10,622,374 | |
| 324,076 | Institution | 0.31% | 7,476,433 |
FAQ
Who Owns Nurix Therapeutics, Inc. (NRIX)?
According to the latest TipRanks data, approximately 0.75% of the company's stock is held by institutional investors, 0.17% is held by insiders, and 64.43% is held by retail investors.
What percentage of Nurix Therapeutics, Inc. (NRIX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.75% of Nurix Therapeutics, Inc. (NRIX) stock is held by institutional investors.
What percentage of Nurix Therapeutics, Inc. (NRIX) stock is held by retail investors?
According to the latest TipRanks data, approximately 64.43% of Nurix Therapeutics, Inc. (NRIX) stock is held by retail investors.
Who owns the most shares of Nurix Therapeutics, Inc. (NRIX)?
Vanguard owns the most shares of Nurix Therapeutics, Inc. (NRIX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.